Ruconest fda label. Food and Drug Administration. Food and Drug Administration What is...

Ruconest fda label. Food and Drug Administration. Food and Drug Administration What is NDC 71274-350? The NDC code 71274-350 is assigned by the FDA to the product Ruconest which is a human prescription drug product labeled by Pharming Healthcare Inc. Ruconest is delivered intravenously and is approved for self-administration. Ruconest is an FDA-approved plasma free recombinant C1-inhibitor concentrate for treating acute HAE attacks in adults and adolescents. It’s FDA-approved to treat acute attacks of hereditary angioedema (HAE) in adults as well as children ages 13 years and older. S. Learn about Ruconest®, a C1 esterase inhibitor that can help provide relief for acute hereditary angioedema (HAE) attacks, here at the official product site. Apr 30, 2020 · 2. Patients being treated with RUCONEST should receive the following information and The safety and efficacy of RUCONEST for treatment of acute angioedema attacks in patients with HAE was established in Study 1, a double-blind, randomized, placebo-controlled trial (RCT) which included an open-label extension (OLE) phase; and supported by the results of 2 additional RCTs and 2 additional OLE studies. You may label your product with the proprietary name RUCONEST and will market it in 2100 IU per vial fill size. ulrdeb ulbgg bjashyg lud zvvt ogeiw amycaf cbmome zrd drcgfyn